Interferon Regulatory Factor 7 Protects Against Vascular Smooth Muscle Cell Proliferation and Neointima Formation
Open Access
- 16 September 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 3 (5) , e001309
Abstract
Background: Interferon regulatory factor 7 ( IRF 7), a member of the interferon regulatory factor family, plays important roles in innate immunity and immune cell differentiation. However, the role of IRF 7 in neointima formation is currently unknown. Methods and Results: Significant decreases in IRF 7 expression were observed in vascular smooth muscle cells ( VSMC s) following carotid artery injury in vivo and platelet‐derived growth factor‐ BB ( PDGF ‐ BB ) stimulation in vitro. Compared with non‐transgenic ( NTG ) controls, SMC ‐specific IRF 7 transgenic ( IRF 7‐ TG ) mice displayed reduced neointima formation and VSMC proliferation in response to carotid injury, whereas a global knockout of IRF 7 ( IRF 7‐ KO ) resulted in the opposite effect. Notably, a novel IRF 7‐ KO rat strain was successfully generated and used to further confirm the effects of IRF 7 deletion on the acceleration of intimal hyperplasia based on a balloon injury‐induced vascular lesion model. Mechanistically, IRF 7's inhibition of carotid thickening and the expression of VSMC proliferation markers was dependent on the interaction of IRF 7 with activating transcription factor 3 ( ATF 3) and its downstream target, proliferating cell nuclear antigen ( PCNA ). The evidence that IRF 7/ ATF 3‐double‐ TG ( DTG ) and IRF 7/ ATF 3‐double‐ KO ( DKO ) mice abolished the regulatory effects exhibited by the IRF 7‐ TG and IRF 7‐ KO mice, respectively, validated the underlying molecular events of IRF 7‐ ATF 3 interaction. Conclusions: These findings demonstrated that IRF 7 modulated VSMC proliferation and neointima formation by interacting with ATF 3, thereby inhibiting the ATF 3‐mediated induction of PCNA transcription. The results of this study indicate that IRF 7 is a novel modulator of neointima formation and VSMC proliferation and may represent a promising target for vascular disease therapy.Keywords
This publication has 60 references indexed in Scilit:
- A FOXO3–IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responsesNature, 2012
- Toll-Like Receptor 7 Preconditioning Induces Robust Neuroprotection Against Stroke by a Novel Type I Interferon-Mediated MechanismStroke, 2012
- Multiple Preconditioning Paradigms Converge on Interferon Regulatory Factor-Dependent Signaling to Promote Tolerance to Ischemic Brain InjuryThe Journal of Neuroscience, 2011
- Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targetingNucleic Acids Research, 2011
- ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cellsRetrovirology, 2011
- Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overloadProceedings of the National Academy of Sciences, 2010
- Activation of IL-27 p28 Gene Transcription by Interferon Regulatory Factor 8 in Cooperation with Interferon Regulatory Factor 1Journal of Biological Chemistry, 2010
- Essential Role of Mitochondrial Antiviral Signaling, IFN Regulatory Factor (IRF)3, and IRF7 in Chlamydophila pneumoniae -Mediated IFN-β Response and Control of Bacterial Replication in Human Endothelial CellsThe Journal of Immunology, 2010
- Protective Effect of Hydrogen Sulfide on Balloon Injury-Induced Neointima Hyperplasia in Rat Carotid ArteriesThe American Journal of Pathology, 2007
- Platelet‐derived growth factor regulates actin isoform expression and growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cellsJournal of Cellular Physiology, 1990